Chitosan-Based Mucoadhesive Vaginal Tablets for Controlled Release of the Anti-HIV Drug Tenofovir

Vaginal microbicides have the potential to give women at high risk of contracting HIV the option of self-protection by preventing the sexual transmission of the virus. In this paper, mucoadhesive vaginal tablets based on chitosan, alone and in combination with pectin and locust bean gum, were develo...

Full description

Bibliographic Details
Main Authors: Raúl Cazorla-Luna, Fernando Notario-Pérez, Araceli Martín-Illana, Roberto Ruiz-Caro, Aitana Tamayo, Juan Rubio, María Dolores Veiga
Format: Article
Language:English
Published: MDPI AG 2019-01-01
Series:Pharmaceutics
Subjects:
Online Access:http://www.mdpi.com/1999-4923/11/1/20
_version_ 1828151826062508032
author Raúl Cazorla-Luna
Fernando Notario-Pérez
Araceli Martín-Illana
Roberto Ruiz-Caro
Aitana Tamayo
Juan Rubio
María Dolores Veiga
author_facet Raúl Cazorla-Luna
Fernando Notario-Pérez
Araceli Martín-Illana
Roberto Ruiz-Caro
Aitana Tamayo
Juan Rubio
María Dolores Veiga
author_sort Raúl Cazorla-Luna
collection DOAJ
description Vaginal microbicides have the potential to give women at high risk of contracting HIV the option of self-protection by preventing the sexual transmission of the virus. In this paper, mucoadhesive vaginal tablets based on chitosan, alone and in combination with pectin and locust bean gum, were developed for the sustained release of tenofovir (an antiretroviral drug). The formulations were placed in simulant vaginal fluid (SVF) to swell, and Hg porosity and SEM microscopy were used for the microstructural characterization of the swelling witnesses. The results show that the association of pectin and chitosan generated polyelectrolyte complexes and produced a robust system able to maintain its structure during the swelling process, when small pores are formed. Drug release and bovine vaginal mucoadhesion studies were performed in SVF showing that tenofovir-controlled dissolution profiles and adhesion to the mucosa were conditioned by the swelling processes of the polymer/s in each formulation. Tablets based on chitosan/pectin have the most homogeneous tenofovir dissolution profiles and last up to 96 h, remaining attached to the vaginal mucosa for the same period. These formulations can therefore be considered a good option for the self-protection of women from the sexual transmission of HIV.
first_indexed 2024-04-11T22:03:08Z
format Article
id doaj.art-57e0f52e35f1483f830d34e71c0de5f2
institution Directory Open Access Journal
issn 1999-4923
language English
last_indexed 2024-04-11T22:03:08Z
publishDate 2019-01-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj.art-57e0f52e35f1483f830d34e71c0de5f22022-12-22T04:00:51ZengMDPI AGPharmaceutics1999-49232019-01-011112010.3390/pharmaceutics11010020pharmaceutics11010020Chitosan-Based Mucoadhesive Vaginal Tablets for Controlled Release of the Anti-HIV Drug TenofovirRaúl Cazorla-Luna0Fernando Notario-Pérez1Araceli Martín-Illana2Roberto Ruiz-Caro3Aitana Tamayo4Juan Rubio5María Dolores Veiga6Departamento de Farmacia Galénica y Tecnología Alimentaria, Facultad de Farmacia, Universidad Complutense de Madrid, 28040 Madrid, SpainDepartamento de Farmacia Galénica y Tecnología Alimentaria, Facultad de Farmacia, Universidad Complutense de Madrid, 28040 Madrid, SpainDepartamento de Farmacia Galénica y Tecnología Alimentaria, Facultad de Farmacia, Universidad Complutense de Madrid, 28040 Madrid, SpainDepartamento de Farmacia Galénica y Tecnología Alimentaria, Facultad de Farmacia, Universidad Complutense de Madrid, 28040 Madrid, SpainInstituto de Cerámica y Vidrio, Consejo Superior de Investigaciones Científicas, 28049 Madrid, SpainInstituto de Cerámica y Vidrio, Consejo Superior de Investigaciones Científicas, 28049 Madrid, SpainDepartamento de Farmacia Galénica y Tecnología Alimentaria, Facultad de Farmacia, Universidad Complutense de Madrid, 28040 Madrid, SpainVaginal microbicides have the potential to give women at high risk of contracting HIV the option of self-protection by preventing the sexual transmission of the virus. In this paper, mucoadhesive vaginal tablets based on chitosan, alone and in combination with pectin and locust bean gum, were developed for the sustained release of tenofovir (an antiretroviral drug). The formulations were placed in simulant vaginal fluid (SVF) to swell, and Hg porosity and SEM microscopy were used for the microstructural characterization of the swelling witnesses. The results show that the association of pectin and chitosan generated polyelectrolyte complexes and produced a robust system able to maintain its structure during the swelling process, when small pores are formed. Drug release and bovine vaginal mucoadhesion studies were performed in SVF showing that tenofovir-controlled dissolution profiles and adhesion to the mucosa were conditioned by the swelling processes of the polymer/s in each formulation. Tablets based on chitosan/pectin have the most homogeneous tenofovir dissolution profiles and last up to 96 h, remaining attached to the vaginal mucosa for the same period. These formulations can therefore be considered a good option for the self-protection of women from the sexual transmission of HIV.http://www.mdpi.com/1999-4923/11/1/20vaginal preexposure prophylaxis of HIVtenofovir controlled releasemucoadhesive vaginal tabletsnatural polymers combinationchitosanpectinlocust bean gum
spellingShingle Raúl Cazorla-Luna
Fernando Notario-Pérez
Araceli Martín-Illana
Roberto Ruiz-Caro
Aitana Tamayo
Juan Rubio
María Dolores Veiga
Chitosan-Based Mucoadhesive Vaginal Tablets for Controlled Release of the Anti-HIV Drug Tenofovir
Pharmaceutics
vaginal preexposure prophylaxis of HIV
tenofovir controlled release
mucoadhesive vaginal tablets
natural polymers combination
chitosan
pectin
locust bean gum
title Chitosan-Based Mucoadhesive Vaginal Tablets for Controlled Release of the Anti-HIV Drug Tenofovir
title_full Chitosan-Based Mucoadhesive Vaginal Tablets for Controlled Release of the Anti-HIV Drug Tenofovir
title_fullStr Chitosan-Based Mucoadhesive Vaginal Tablets for Controlled Release of the Anti-HIV Drug Tenofovir
title_full_unstemmed Chitosan-Based Mucoadhesive Vaginal Tablets for Controlled Release of the Anti-HIV Drug Tenofovir
title_short Chitosan-Based Mucoadhesive Vaginal Tablets for Controlled Release of the Anti-HIV Drug Tenofovir
title_sort chitosan based mucoadhesive vaginal tablets for controlled release of the anti hiv drug tenofovir
topic vaginal preexposure prophylaxis of HIV
tenofovir controlled release
mucoadhesive vaginal tablets
natural polymers combination
chitosan
pectin
locust bean gum
url http://www.mdpi.com/1999-4923/11/1/20
work_keys_str_mv AT raulcazorlaluna chitosanbasedmucoadhesivevaginaltabletsforcontrolledreleaseoftheantihivdrugtenofovir
AT fernandonotarioperez chitosanbasedmucoadhesivevaginaltabletsforcontrolledreleaseoftheantihivdrugtenofovir
AT aracelimartinillana chitosanbasedmucoadhesivevaginaltabletsforcontrolledreleaseoftheantihivdrugtenofovir
AT robertoruizcaro chitosanbasedmucoadhesivevaginaltabletsforcontrolledreleaseoftheantihivdrugtenofovir
AT aitanatamayo chitosanbasedmucoadhesivevaginaltabletsforcontrolledreleaseoftheantihivdrugtenofovir
AT juanrubio chitosanbasedmucoadhesivevaginaltabletsforcontrolledreleaseoftheantihivdrugtenofovir
AT mariadoloresveiga chitosanbasedmucoadhesivevaginaltabletsforcontrolledreleaseoftheantihivdrugtenofovir